Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ELYM

Eliem Therapeutics (ELYM)

Eliem Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELYM
DateTimeSourceHeadlineSymbolCompany
12/04/202406:27PR Newswire (US)Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law FirmNASDAQ:ELYMEliem Therapeutics Inc
11/04/202421:00GlobeNewswire Inc.Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private PlacementNASDAQ:ELYMEliem Therapeutics Inc
05/03/202403:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELYMEliem Therapeutics Inc
15/11/202308:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELYMEliem Therapeutics Inc
14/11/202309:13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELYMEliem Therapeutics Inc
11/08/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELYMEliem Therapeutics Inc
20/07/202320:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELYMEliem Therapeutics Inc
20/07/202320:45GlobeNewswire Inc.Eliem Therapeutics Announces Plans to Explore Strategic AlternativesNASDAQ:ELYMEliem Therapeutics Inc
23/05/202307:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELYMEliem Therapeutics Inc
23/05/202307:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELYMEliem Therapeutics Inc
20/05/202306:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
12/05/202306:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
12/05/202306:10GlobeNewswire Inc.Eliem Therapeutics Reports First Quarter Financial Results and Business HighlightsNASDAQ:ELYMEliem Therapeutics Inc
07/04/202306:17Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ELYMEliem Therapeutics Inc
07/04/202306:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ELYMEliem Therapeutics Inc
17/03/202307:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
15/03/202308:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELYMEliem Therapeutics Inc
09/03/202308:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELYMEliem Therapeutics Inc
07/03/202308:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
07/03/202308:50Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ELYMEliem Therapeutics Inc
07/03/202308:10GlobeNewswire Inc.Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business HighlightsNASDAQ:ELYMEliem Therapeutics Inc
15/02/202306:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELYMEliem Therapeutics Inc
10/02/202308:01GlobeNewswire Inc.Eliem Therapeutics Provides Strategic Update and Announces Leadership TransitionNASDAQ:ELYMEliem Therapeutics Inc
09/02/202308:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELYMEliem Therapeutics Inc
21/12/202208:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELYMEliem Therapeutics Inc
30/11/202223:00GlobeNewswire Inc.Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual ConferenceNASDAQ:ELYMEliem Therapeutics Inc
16/11/202218:55TipRanksSVB Securities Sticks to Their Buy Rating for Eliem Therapeutics (ELYM)NASDAQ:ELYMEliem Therapeutics Inc
15/11/202222:16TipRanksH.C. Wainwright Sticks to Their Buy Rating for Eliem Therapeutics (ELYM)NASDAQ:ELYMEliem Therapeutics Inc
14/11/202222:10GlobeNewswire Inc.Eliem Therapeutics Reports Third Quarter Financial and Business HighlightsNASDAQ:ELYMEliem Therapeutics Inc
08/11/202223:00GlobeNewswire Inc.Eliem Therapeutics to Participate at Two Upcoming Investor ConferencesNASDAQ:ELYMEliem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ELYM